Switch to
More onapp

How to use scorecard? Learn more

Kilitch Drugs (India) Ltd

KILITCH
Health CarePharmaceuticals
SmallcapWith a market cap of ₹541 cr, stock is ranked 1,724
Moderate RiskStock is 2.97x as volatile as Nifty
338.351.45 (+0.43%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹541 cr, stock is ranked 1,724
Moderate RiskStock is 2.97x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
37.11
PB RatioPB Ratio
3.60
Dividend YieldDiv. Yield
Sector PESector PE
44.33
Sector PBSector PB
6.05
Sector Div YldSctr Div Yld
0.57%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Kilitch Drugs (India) Limited is engaged in the development and operations of pharmaceutical business. The Company's services range from manufacturing to marketing a host of formulations in solid, liquid and parenteral forms.

Financial TrendFinancial statements 

202120222023202471.19117.14142.52158.853.757.3610.4614.60
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Trading Window-XBRL 
Announced OnJun 29, 2024

KILITCH DRUGS (INDIA) LIMITED has informed the Exchange about Closure of Trading Window | Download

KILITCH DRUGS (INDIA) LIMITED has informed the Exchange about Closure of Trading Window | Download

Loss/Duplicate-Share Certificate-XBRL 
Announced OnJun 5, 2024

Kilitch Drugs (India) Limited has informed the Exchange about Loss of share certificates | Download

Kilitch Drugs (India) Limited has informed the Exchange about Loss of share certificates | Download

Cash Dividend 
Ex. DateSep 20, 2019

Final • Div/Share: ₹ 0.5

See all events